Mycophenolate Mofetil in Minimal Change NephrosisALFRED, R; SOYIBO, A. K.West indian medical journal. 2010, Vol 59, Num 3, pp 330-331, issn 0043-3144, 2 p.Article

Mycophenolate mofetil in dermatologyORVIS, Alissa K; WESSON, Stanton K; BREZA, Thomas S et al.Journal of the American Academy of Dermatology. 2009, Vol 60, Num 2, pp 183-199, issn 0190-9622, 17 p.Article

Mycophenolate mofetil for ocular myastheniaCHAN, Jane W.Journal of neurology. 2008, Vol 255, Num 4, pp 510-513, issn 0340-5354, 4 p.Article

Pemphigoïde anti-p200: rémission sous mycophénolate mofétil (Cellcept^®) = Anti-p200 pemphigoid: Remission under mycophenolate mofetil (Cellcept^®)RAFFIN, D; DELAPLACE, M; ROUSSEL, A et al.Annales de dermatologie et de vénéréologie. 2013, Vol 140, Num 12, pp 784-787, issn 0151-9638, 4 p.Article

Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deteriorationMETER-KRIESCHE, Herwig-Ulf; STEFFEN, Bettina J; HOCHBERG, Alan M et al.Transplantation. 2003, Vol 75, Num 8, pp 1341-1346, issn 0041-1337, 6 p.Conference Paper

Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: Results at 6 monthsGONWA, Thomas; MENDEZ, Robert; YANG, Harold C et al.Transplantation. 2003, Vol 75, Num 8, pp 1213-1220, issn 0041-1337, 8 p.Conference Paper

Mycophenolate mofetil treatment in resistant myositisPISONI, C. N; CUADRADO, M. J; KHAMASHTA, M. A et al.Rheumatology (Oxford. Print). 2007, Vol 46, Num 3, pp 516-518, issn 1462-0324, 3 p.Article

Treatment of Mediastinal Fibrosis with Mycophenolate MofetilWITSCHI, Michael; GUGGER, Mathias; NICOD, Laurent P et al.Respiration (Basel). 2009, Vol 78, Num 3, pp 330-333, issn 0025-7931, 4 p.Article

Mycophenolate Mofetil Impairs Transduction of Single-Stranded Adeno-Associated Viral VectorsMONTENEGRO-MIRANDA, Paula S; TEN BLOEMENDAAL, Lysbeth; KUNNE, Cindy et al.Human gene therapy. 2011, Vol 22, Num 5, pp 605-612, issn 1043-0342, 8 p.Article

Efficacy of mycophenolate mofetil combined with very low-dose cyclosporine microemulsion in long-term liver-transplant patients with renal dysfunctionCANTAROVICH, Marcelo; TZIMAS, George N; BARKUN, J et al.Transplantation. 2003, Vol 76, Num 1, pp 98-102, issn 0041-1337, 5 p.Article

Mycophenolate mofetil levels in stable kidney transplant recipientsFERNANDEZ, A; MARCEN, R; BURGOS, J et al.Transplantation proceedings. 2007, Vol 39, Num 7, pp 2182-2184, issn 0041-1345, 3 p.Conference Paper

Long-term benefit of mycophenolate mofetil in renal transplantationLANG, Philippe; PARDON, Agathe; AUDARD, Vincent et al.Transplantation. 2005, Vol 79, Num 3, pp S47-S48, issn 0041-1337, SUPConference Paper

Impact of mycophenolate mofetil loading on drug exposure in the early posttransplant periodKIBERD, B. A; PUTHENPARUMPIL, J. J; FRASER, A et al.Transplantation proceedings. 2005, Vol 37, Num 5, pp 2320-2323, issn 0041-1345, 4 p.Article

Mycophenolate mofetil in pediatric renal transplantationETTENGER, Robert; SARWAL, Minnie M.Transplantation. 2005, Vol 80, Num 2, pp S201-S210, issn 0041-1337, SUPArticle

The pharmacokinetics of mycophenolate mofetil in Thai kidney transplant recipientsJIRASIRITHAM, S; SUMETHKUL, V; MAVICHAK, V et al.Transplantation proceedings. 2004, Vol 36, Num 7, pp 2076-2078, issn 0041-1345, 3 p.Conference Paper

Mycophenolate mofetil increases adhesion capacity of tumor cells in vitroBLAHETA, Roman A; BOGOSSIAN, Harilaos; CINATL, Jindrich JR et al.Transplantation. 2003, Vol 76, Num 12, pp 1735-1741, issn 0041-1337, 7 p.Article

Mycophenolate mofetil inhibits tumor growth and angiogenesis in vitro but has variable antitumor effects in vivo, possibly related to bioavailabilityKOEHL, Gudrun E; WAGNER, Ferdinand; STOELTZING, Oliver et al.Transplantation. 2007, Vol 83, Num 5, pp 607-614, issn 0041-1337, 8 p.Article

Bioequivalence of enteric-coated mycophenolate sodium and mycophenolate mofetil : A meta-analysis of three studies in stable renal transplant recipientsJOHNSTON, Atholl; XIANG HE; HOLT, David W et al.Transplantation. 2006, Vol 82, Num 11, pp 1413-1418, issn 0041-1337, 6 p.Article

Immunosuppression with cyclosporine a and mycophenolate mofetil after penetrating high-risk keratoplasty : A retrospective studyBIRNBAUM, Florian; BÖHRINGER, Daniel; SOKOLOVSKA, Yevgenia et al.Transplantation. 2005, Vol 79, Num 8, pp 964-968, issn 0041-1337, 5 p.Article

Toxicity-sparing protocols using mycophenolate mofetil in renal transplantationLAND, Walter; VINCENTI, Flavio.Transplantation. 2005, Vol 80, Num 2, pp S221-S234, issn 0041-1337, SUPArticle

Use of mycophenolate mofetil in autoimmune and renal diseasesAPPEL, Gerald B; RADHAKRISHNAN, Jai; GINZLER, Ellen M et al.Transplantation. 2005, Vol 80, Num 2, pp S265-S271, issn 0041-1337, SUPArticle

Tacrolimus or cyclosporine: Which is the better partner for mycophenolate mofetil in heart transplant recipients?MEISER, Bruno M; GROETZNER, Jan; REICHART, Bruno et al.Transplantation. 2004, Vol 78, Num 4, pp 591-598, issn 0041-1337, 8 p.Article

Enteric-coated mycophenolate sodium: Therapeutic equivalence to mycophenolate mofetil in de novo renal transplant patientsSOLLINGER, H.Transplantation proceedings. 2004, Vol 36, Num 2S, pp 517S-520S, issn 0041-1345, SUPArticle

Mycophenolate mofetil (MMF) : Firing at the atherosclerotic plaque from different angles?VAN LEUVEN, Sander I; KASTELEIN, John J. P; ALLISON, Anthony C et al.Cardiovascular research. 2006, Vol 69, Num 2, pp 341-347, issn 0008-6363, 7 p.Article

Activation of the purine salvage pathway in mononuclear cells of cardiac recipients treated with mycophenolate mofetilDEVYATKO, Elena; ZUCKERMANN, Andreas; BOHDJALIAN, Arthur et al.Transplantation. 2006, Vol 82, Num 1, pp 113-118, issn 0041-1337, 6 p.Article